Enjoy complimentary customisation on priority with our Enterprise License!
The continuous positive airway pressure (CPAP) devices market size is forecast to increase by USD 1.33 billion, at a CAGR of 6.35% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of sleep apnea and respiratory disorders worldwide. According to the American Sleep Apnea Association, an estimated 22 million Americans have sleep apnea, and this number is projected to rise. The market is also driven by the increasing number of partnerships and collaborations among key players to innovate and expand their product offerings. However, frequent product recalls due to quality issues pose a challenge to market growth. Manufacturers must prioritize product safety and quality to maintain consumer trust and ensure regulatory compliance. Additionally, advancements in technology, such as wireless connectivity and wearable devices, are expected to create new opportunities in the market. Overall, the CPAP devices market is poised for steady growth, driven by the increasing prevalence of sleep disorders and technological advancements, while navigating the challenges of product recalls and regulatory compliance. It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2018 to 2022.
To learn more about this report, View Report Sample
The market is pivotal in addressing respiratory disorders, particularly undiagnosed sleep apnea. Following FDA emergency policy updates, healthcare facilities are exploring ventilator substitutes and innovative therapies, including alternative treatments like mandibular advancing devices. The aging population and rising healthcare spending are driving demand for CPAP devices in hospitals and private clinics, aiming to improve sleep quality and reduce health risks associated with cardiovascular disease. With product segmentation catering to both pediatric and adult patients, the market is also benefiting from advancements in remote patient monitoring and noise-reducing technology. Enhanced sleep services and public health initiatives further support the growing patient pool and the need for effective sleep apnea testing and management. The market is vital for respiratory assistance therapy, addressing disorders exacerbated by unhealthy dietary habits and limited physical activity. Innovations like noise-reducing technology enhance patient comfort, while CPAP devices serve as crucial alternatives to ventilators. Integrating mandibular advancing devices and other medical devices helps reduce mortality related to respiratory conditions.
The increasing prevalence of sleep apnea and respiratory disorders is notably driving the CPAP devices market growth. The increased prevalence of sleep apnea and the rising number of preterm infants have resulted in high demand for CPAP devices. According to the Sleep Foundation data, the number of preterm infants was the highest in developing countries such as India, China, Pakistan, Indonesia, Bangladesh, and the Philippines. The increased prevalence of sleep apnea and the rising number of preterm infants have resulted in high demand for CPAP devices.
Moreover, these devices consist of headgear (straps), filters, humidifiers, tubes, masks, and nasal pillows. These devices work by improving breathing and reducing the need for steroid treatment for the lungs. They deliver CPAP through nasal masks and reduce daytime sleepiness in individuals with moderate to severe sleep apnea. The improved quality of sleep provided by these devices has generated interest among prospective consumers and end-users, which is leading to the growth of the global CPAP devices market during the forecast period.
The increasing number of partnerships and collaborations is the key trend driving the CPAP devices market growth. The increasing number of partnerships and collaborations is likely to drive the growth of the global CPAP devices market during the forecast period. companies are opting for business strategies, such as partnerships and collaborations, with end-users and medical technology companies, to improve their distribution channels and upgrade their product portfolios by integrating software tools into their devices, which can drive the growth of the global CPAP devices market.
Moreover, Philips Respironics has collaborated with Inspire Medical Systems to develop an implantable device for sleep apnea. Overall, the increasing number of partnerships and collaborations in the US Continuous Positive Airway Pressure (CPAP) market is a positive sign for patients and the healthcare industry. By working together, companies can develop innovative solutions that improve patient outcomes and reduce the burden of respiratory disorders on healthcare systems. Thus, the increasing number of collaborations and partnerships is expected to drive the growth of the US CPAP devices market during the forecast period, fostering advancements in technology and expanding access to effective treatments for sleep apnea and other related conditions.
The major challenge impeding the continuous positive airway pressure market growth is the regulatory challenges. The CPAP devices market is highly regulated, and manufacturers must adhere to various guidelines and standards set by regulatory bodies, such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulations are put in place to ensure the safety and efficacy of CPAP devices, and they cover aspects such as their design, manufacturing, labeling, and marketing. One of the biggest regulatory challenges facing CPAP device manufacturers is obtaining regulatory approval for new products. The process of obtaining regulatory approval can be time-consuming and expensive, and manufacturers must provide extensive data on the safety and efficacy of their products to obtain clearance.
However, another challenge is complying with frequently changing regulations. Regulatory agencies often update and modify their guidelines in response to new developments and emerging technologies, and manufacturers must stay up to date with these changes to avoid non-compliance issues. In addition, there are also challenges related to international regulations and standards. Different countries have different requirements for regulatory approval, and manufacturers must navigate a complex web of regulations and standards to sell their products in different markets. Thus, the regulatory challenges hinder the growth of the global CPAP devices market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovatorâs stage to the laggardâs stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
BMC MEDICAL CO. LTD.: The company offers 6 series Continuous Positive Airway Pressure Devices masks such as N6, F6, P6, BMC NM2, BMC FM1A, and F5AS.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth by the devices segment will be significant during the forecast period. The devices segment accounts for the largest share of the global continuous positive airway pressure (CPAP) devices market. This segment is expected to grow during the forecast period, owing to factors such as the increasing number of product launches, rising prevalence of sleep apnea, business strategies adopted by key companies, and favorable reimbursement policies for CPAP devices.
Get a glance at the market contribution of various segments View the PDF Sample
The devices segment was valued at USD 2.40 billion in 2018. The adoption of mHealth technology by key companies to make CPAP therapy more efficient will increase the adoption of CPAP devices, as they help to monitor patients' conditions remotely. Mobile health (mHealth) is a promising way of providing remote and easy clinical control for follow-ups and support to CPAP devices. Key companies are developing mobile health platforms that connect wirelessly to CPAP machines and care providers, which enables patients to use these machines at home. For instance, Koninklijke Philips NV developed Dream Mapper, a sleep-tracking app, while ResMed developed the myAir app, which tracks the patients' treatment via an iOS app, giving users access to their daily sleep patterns and coaching tips. Moreover, favorable reimbursement policies for CPAP devices from government organizations will propel the growth of the market.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavioâs analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The CPAP devices market in North America is expected to grow during the forecast period. Factors such as the rising prevalence of sleep apnea, new product launches, the presence of key players, and favorable reimbursement policies for sleep apnea therapy are anticipated to drive the growth of the market in the region during the forecast period. companies are focusing on increasing the sales of their products by adopting business strategies, such as collaborations with local and regional players, new product launches, the development of innovative products, which, along with the rising approvals for CPAP devices by regulatory authorities, will augment the growth of the market in North America.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
The market caters to the increasing prevalence of Sleep Apnea and Hypopnea Syndrome among the Geriatric Population. CPAP devices are essential medical equipment used to manage Obstructive Sleep Apnea (OSA) and other respiratory disorders. These devices maintain a constant air pressure in the user's airway to prevent collapsing during sleep. Key factors driving the growth of the CPAP devices market include the increasing prevalence of undiagnosed and treated sleep apnea, comorbidities like Obesity, Hypertension, Diabetes, Cardiovascular diseases, Depression, and life expectancy increase. The market is segmented into Manual and Automatic CPAP devices, with the automatic segment gaining popularity due to its ability to adjust pressure settings based on the user's breathing pattern. Products like Heated Humidifiers and Telemedicine services enhance patient comfort, while Home Based Treatment and Home Care Settings facilitate easy access to CPAP therapy. The FDA's emergency policy allowing remote initiation and follow-up of CPAP therapy during the pandemic further boosts market growth. Competitive pricing, reverse engineering, contamination risks, and patient compliance are significant challenges for CPAP device manufacturers. The healthcare equipment market is competitive, with key players including Philips Respironics, ResMed, Fisher & Paykel Healthcare, and DeVilbiss Healthcare. The market also witnesses trends like Infusion Therapy integration, Aerosolization technology, and Virtual care solutions to improve patient outcomes. Insurance coverage and sleep disorders awareness campaigns are crucial factors influencing market growth.
Market Scope |
|
Report Coverage |
Details |
Page number |
164 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.35% |
Market growth 2024-2028 |
USD 1.33 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.63 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 45% |
Key countries |
US, Germany, China, UK, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
BMC MEDICAL CO. LTD., CASCO BAY MOLDING, Compumedics Ltd., DeVilbiss Healthcare GmbH, Dragerwerk AG and Co. KGaA, Ess Pee Enterprises, Fisher and Paykel Healthcare Corp. Ltd., Hamilton Co., Koninklijke Philips N.V., Lowenstein Medical Technology GmbH and Co. KG, Manish Enterprises, Medtronic, Narang Medical Ltd., NXP Semiconductors NV, ResMed Inc., Sleepnet Corp., Smiths Group Plc, TG Eakin Ltd., The Cleveland Clinic Foundation, and Vyaire Medical Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.